Read more

November 01, 2020
1 min read
Save

UCLA names inaugural chair in integrative oncology

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

John A. Glaspy, MD, MPH, has been named the inaugural Simms/Mann Family Foundation endowed chair in integrative oncology at University of California, Los Angeles.

Glaspy is professor of medicine and hematology/oncology at David Geffen School of Medicine at UCLA, as well as chair of scientific protocol review at UCLA Jonsson Comprehensive Cancer Center.

The chair is funded through a $2 million gift from the Simms/Mann Family Foundation, which supports UCLA’s integrative psychosocial care for people with cancer and their families who are dealing with the physical, emotional and psychological burdens of cancer and its treatment.

“Dr. Glaspy has always been a believer in providing a comprehensive treatment approach to [patients with cancer] and their families, emphasizing whole person wellness rather than just simply seeing them as degrees of disease,” Victoria Mann Simms, PhD, one of the foundation’s leaders, said in a press release.

Glaspy also is medical director for Simms/Mann UCLA Center of Integrative Oncology, which provides support groups and psychosocial care, as well as information, guidance and support related to nutrition, supplements, mind-body approaches and psychological concerns.

John A. Glaspy, MD, MPH
John A. Glaspy

“I am honored to be the first holder of the Simms/Mann Family Foundation endowed chair in integrative oncology and grateful for their tremendous generosity,” Glaspy said. “I am also especially proud of what the Simms/Mann UCLA Center of Integrative Oncology team has built to provide [patients with cancer] with a much more comprehensive treatment that goes beyond conventional medical care. I am committed to continuing the work of the center and bringing the services offered to all our community oncology clinics.”

Glaspy is involved with clinical trials of treatments for melanoma and breast cancer, as well as trials designed to evaluate supportive care approaches.